MZ
Mohammed Zahid Rinallikhan Sipai
About Mohammed Zahid Rinallikhan Sipai
Data last updated:
Mohammed Zahid Rinallikhan Sipai is a Director at Ishaana Formulations Private Limited (since 2016), Director at Aurora Farmabio Private Limited (since 2021) and Designated Partner at Santander Farma Bio Llp (since 2017). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3.61 Cr; the largest is Ishaana Formulations Private Limited at ₹1.98 Cr (FY 2020). Earlier, Mohammed Zahid Rinallikhan Sipai was an Additional Director at Ishaanav Nutraceuticals Private Limited (2017–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ishaana Formulations Private Limited U74999UR2016PTC007400 | Director | 15 Nov 2016 | 2016 | ₹1.98 Cr (FY 2020) | Active |
| Aurora Farmabio Private Limited U24290GJ2021PTC127436 | Director | 22 Nov 2021 | 2021 | ₹1.62 Cr (FY 2024) | Active |
| Santander Farma Bio Llp AAK-2200 | Designated Partner | 04 Aug 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ishaanav Nutraceuticals Private Limited U74999UR2016PTC007359 | Additional Director | 28 Dec 2017 | 2016 | ₹21.09 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mohammed Zahid Rinallikhan Sipai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deva Sena Pathi | 06465093 | Ishaana Formulations Private Limited , Santander Farma Bio Llp | Director |
| Venugopal Ananthanarayanan Thangaraj | 02603568 | Ishaana Formulations Private Limited | Director |
| Premjith Balakrishnan | 07504984 | Aurora Farmabio Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Zahid Rinallikhan Sipai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Zahid Rinallikhan Sipai
Mohammed Zahid Rinallikhan Sipai currently holds 3 directorships: Ishaana Formulations Private Limited (Director, since 15 Nov 2016, revenue ₹1.98 Cr (FY 2020)); Aurora Farmabio Private Limited (Director, since 22 Nov 2021, revenue ₹1.62 Cr (FY 2024)); Santander Farma Bio Llp (Designated Partner, since 04 Aug 2017).
Mohammed Zahid Rinallikhan Sipai was first appointed on 15 Nov 2016 as Director at Ishaana Formulations Private Limited. The most recent appointment on record is 22 Nov 2021 at Aurora Farmabio Private Limited.
The 2 current companies of Mohammed Zahid Rinallikhan Sipai that report revenue have a combined latest revenue of ₹3.61 Cr: Ishaana Formulations Private Limited ₹1.98 Cr (FY 2020); Aurora Farmabio Private Limited ₹1.62 Cr (FY 2024).
Mohammed Zahid Rinallikhan Sipai held 1 earlier board appointment: Ishaanav Nutraceuticals Private Limited (Additional Director, 28 Dec 2017 to 14 Dec 2019).
The current boards of Mohammed Zahid Rinallikhan Sipai's companies include Deva Sena Pathi (Ishaana Formulations Private Limited), Venugopal Ananthanarayanan Thangaraj (Ishaana Formulations Private Limited), Premjith Balakrishnan (Aurora Farmabio Private Limited).